isogenic cell lines

Thermo Fisher will market Horizon's X-MAN human haploid and diploid isogenic cell line collection. 

The UK-based firm will provide Sanger with more than 200 genetically defined cell lines with cancer-causing mutations, which will guide researchers working on the Genomics of Drug Sensitivity in Cancer project.

Expanding their relationship, the cancer drug developer will use the mutant-and-normal cell line library.

Horizon will develop X-MAN cancer models for the drug developer's therapeutic research programs.

The partners will use Horizon's cell lines to identify unique protein biomarker signatures.

Cambridge, UK-based Horizon will provide GSK with its isogenic cell lines for cancer metabolomics studies.

The drug developer will use Horizon's X-MAN technology in genotype-specific compound tests.

Horizon Discovery also plans to participate in a consortium of "top academic institutions and big pharmas" in the cancer field, a research partnership expected to expand its panel of isogenic cell lines for drug discovery.

The school aims to develop biomarkers for use in cancer diagnostics.

Horizon will use the genetic modeling technology to develop cancer-related screening products and services.

Pages

Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.

Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.

Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.